ArticleCancer prevention research (Philadelphia, Pa.)2014

Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.

Pei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.